Newsletter
13 de April de 2013
Newsletter 2013.02 – Recent developments regarding examination of pharma patent applications
Brazilian PTO’s new Resolution No. 80 of March 19, 2013 sets forth rules for granting priority examination for patent applications related to pharmaceutical products and processes, and equipments and materials related to public health
The Brazilian PTO published Resolution No. 80, on March 19, 2013 in the Official Gazette, which establishes the proceedings for requesting priority examination of patent applications related to pharmaceutical products and processes, and equipments and materials related to public health. We are pleased to hereby enclose a complete English language version of the resolution for your review.
According to the new resolution, now in full force, priority for the examination of patent applications related to public health may be requested by:
Share:
Last related news
4 de November de 2025
ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025
The proposal for reviewing the regulation concerning the general labeling of packaged foods (including beverages, ingredients, additives, and processing aids) was published … ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025
20 de October de 2025
Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age
Last month, Brazil took a major step toward regulating the digital environment for children and adolescents with the enactment of the ECA … Brazil enacts the ECA Digital: a landmark law for children’s rights in the Digital Age
17 de October de 2025
New Rules for Clinical Research: Federal Government Bets on Regulation to Boost Innovation and Investment
Brazil, despite being among the top 20 countries in terms of the number of clinical trials, contributes less than 2% of global … New Rules for Clinical Research: Federal Government Bets on Regulation to Boost Innovation and Investment